enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. FDA approves 1st new drug for schizophrenia in more ... - AOL

   www.aol.com/fda-approves-1st-drug-schizophrenia...

   The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in more than 30 years. Cobenfy, manufactured by Bristol Myers Squibb ...

3. FDA approves new type of schizophrenia drug - AOL

   www.aol.com/news/fda-approves-type-schizophrenia...

   The U.S. Food and Drug Administration (FDA) on Friday approved a new drug used for treating schizophrenia in adults, according to a press release. “This drug takes the first new approach to ...

4. Bristol Myers wins US FDA approval for new type of ...

   www.aol.com/news/us-fda-approves-bristol-myers...

   (Reuters) -The U.S. Food and Drug Administration approved Bristol Myers Squibb's schizophrenia drug late on Thursday, making it the first new type of antipsychotic medicine in decades. The ...

5. Teva Presents Latest Schizophrenia Treatment Research ...

   lite.aol.com/tech/story/0022/20241101/1001010507.htm

   About Schizophrenia Schizophrenia is a chronic, progressive and severely debilitating mental disorder that affects how one thinks, feels and acts. 2 Patients experience an array of symptoms, which may include delusions, hallucinations, disorganized speech or behavior, and impaired cognitive ability. 2,3,4 Approximately 1% of the world’s ...

6. Aripiprazole - Wikipedia

   en.wikipedia.org/wiki/Aripiprazole

   A new long acting injectable version of aripiprazole was approved by the FDA for the treatment of bipolar disorder 1 and schizophrenia on 27 April 2023. [139] [140] In 2024, the European Commission approved this new long acting injectable formulation of aripiprazole for the maintenance treatment of schizophrenia. [141]

7. Xanomeline/trospium chloride - Wikipedia

   en.wikipedia.org/wiki/Xanomeline/trospium_chloride

   The effectiveness of xanomeline/trospium chloride for the treatment of schizophrenia in adults was evaluated in two studies with identical designs. [2] Study 1 (NCT04659161) and study 2 (NCT04738123) were 5-week, randomized, double-blind, placebo-controlled, multi-center studies in adults with a diagnosis of schizophrenia according to DSM-5 ...